Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

NCT01230502 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped insufficient study population to meet study objective

Conditions

Liver Transplant

Interventions

DRUG: Group 1 Donor Specific Regulation (DSR) +, Mycophenolic acid (MPA) monotherapy
OTHER: data and sample collection
OTHER: data and sample collection

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]